Big Pharma delivers another life-saving medical advance, and another demonstration of the folly of price controls.

HIV remains incurable but manageable. Johns Hopkins found a way to silence it long-term using a molecule from the virus itself, offering hope for future gene therapy without daily meds.

Users on Facebook, Instagram and X have shared the same “BREAKING NEWS” message, claiming that “A CURE FOR HIV/AIDS HAS JUST ...

In a significant breakthrough, scientists at Johns Hopkins University have discovered that gene therapy could be a key to forcing HIV into a permanent dormant state, potentially offering a long-term, ...

The FDA has approved Yeztugo (lenacapvir), a twice-yearly injection to prevent HIV infection that could improve adherence ...

A twice-yearly injectable drug, lenacapavir, hailed as a breakthrough in HIV prevention, could be available in Canada by ...

Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response ...

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be HIV-negative to get it.

The US Food and Drug Administration (FDA) has approved lenacapavir, an injectable drug that offers long-lasting protection ...

The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...